{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:44:13Z","timestamp":1791431053994,"version":"4.3.3"},"reference-count":330,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.virusres.2011.09.020","type":"journal-article","created":{"date-parts":[[2011,9,22]],"date-time":"2011-09-22T17:26:43Z","timestamp":1316712403000},"page":"80-99","source":"Crossref","is-referenced-by-count":418,"title":["Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years"],"prefix":"10.1016","volume":"162","author":[{"given":"Peter L.","family":"Collins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Melero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1542\/peds.99.1.93","article-title":"Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group","volume":"99","author":"Anon.","year":"1997","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib0010","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV study group","volume":"102","author":"Anon.","year":"1998","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib0015","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1542\/peds.2006-2223","article-title":"Diagnosis and management of bronchiolitis","volume":"118","author":"Anon.","year":"2006","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.virusres.2011.09.020_bib0020","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1542\/peds.2009-2345","article-title":"From the American Academy of Pediatrics: policy statements \u2013 modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections","volume":"124","author":"Anon.","year":"2009","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1034\/j.1399-3003.1999.14a23.x","article-title":"IL-8 and neutrophil elastase levels in the respiratory tract of infants with RSV bronchiolitis","volume":"14","author":"Abu-Harb","year":"1999","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.virusres.2011.09.020_bib0030","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri1394","article-title":"Neonatal adaptive immunity comes of age","volume":"4","author":"Adkins","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/jcp.23.1.7","article-title":"Pathological changes in virus infections of the lower respiratory tract in children","volume":"23","author":"Aherne","year":"1970","journal-title":"J. Clin. Pathol."},{"issue":"6","key":"10.1016\/j.virusres.2011.09.020_bib0040","doi-asserted-by":"crossref","first-page":"e1249","DOI":"10.1542\/peds.2008-1744","article-title":"A double-blind, placebo-controlled, randomized trial of montelukast for acute bronchiolitis","volume":"122","author":"Amirav","year":"2008","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0045","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0042-6822(92)90203-2","article-title":"Polylactosaminoglycan modification of the respiratory syncytial virus small hydrophobic (SH) protein: a conserved feature among human and bovine respiratory syncytial viruses","volume":"191","author":"Anderson","year":"1992","journal-title":"Virology"},{"issue":"Pt 12","key":"10.1016\/j.virusres.2011.09.020_bib0050","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1099\/vir.0.82165-0","article-title":"Phosphorylation of human respiratory syncytial virus P protein at threonine 108 controls its interaction with the M2-1 protein in the viral RNA polymerase complex","volume":"87","author":"Asenjo","year":"2006","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib0055","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1128\/JVI.72.2.1452-1461.1998","article-title":"The NS1 protein of human respiratory syncytial virus is a potent inhibitor of minigenome transcription and RNA replication","volume":"72","author":"Atreya","year":"1998","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.virusres.2011.09.020_bib0060","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/JVI.63.7.2941-2950.1989","article-title":"Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function","volume":"63","author":"Beeler","year":"1989","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib0065","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/infdis\/168.4.1024","article-title":"Immunogenicity of purified F glycoprotein of respiratory syncytial virus: clinical and immune responses to subsequent natural infection in children","volume":"168","author":"Belshe","year":"1993","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib0070","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1046\/j.1365-2249.2000.01297.x","article-title":"Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry","volume":"121","author":"Bendelja","year":"2000","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/j.virusres.2011.09.020_bib0075","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1086\/515575","article-title":"Immunopathogenesis of respiratory syncytial virus bronchiolitis","volume":"195","author":"Bennett","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2011.09.020_bib0080","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1542\/peds.34.6.753","article-title":"Acute respiratory illness in the premature nursery associated with respiratory syncytial virus infections","volume":"34","author":"Berkovich","year":"1964","journal-title":"Pediatrics"},{"issue":"20","key":"10.1016\/j.virusres.2011.09.020_bib0085","doi-asserted-by":"crossref","first-page":"11259","DOI":"10.1073\/pnas.96.20.11259","article-title":"The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription","volume":"96","author":"Bermingham","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0090","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nm1164","article-title":"Inhibition of respiratory viruses by nasally administered siRNA","volume":"11","author":"Bitko","year":"2005","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib0095","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1128\/JVI.01420-06","article-title":"Nonstructural proteins of respiratory syncytial virus suppress premature apoptosis by an NF-kappaB-dependent, interferon-independent mechanism and facilitate virus growth","volume":"81","author":"Bitko","year":"2007","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib0100","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1086\/322043","article-title":"Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants","volume":"184","author":"Boeckh","year":"2001","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib0105","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1128\/JVI.01297-10","article-title":"The C proteins of human parainfluenza virus type 1 limit double-stranded RNA accumulation that would otherwise trigger activation of MDA5 and protein kinase R","volume":"85","author":"Boonyaratanakornkit","year":"2011","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0110","doi-asserted-by":"crossref","first-page":"e1000254","DOI":"10.1371\/journal.ppat.1000254","article-title":"Positive selection results in frequent reversible amino acid replacements in the G protein gene of human respiratory syncytial virus","volume":"5","author":"Botosso","year":"2009","journal-title":"PLoS Pathog."},{"issue":"23","key":"10.1016\/j.virusres.2011.09.020_bib0115","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1016\/j.vaccine.2006.03.064","article-title":"The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease","volume":"24","author":"Boukhvalova","year":"2006","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.virusres.2011.09.020_bib0120","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1067\/mpd.2000.110531","article-title":"Rates of hospitalization for respiratory syncytial virus infection among children in medicaid","volume":"137","author":"Boyce","year":"2000","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib0125","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/1096-9071(200010)62:2<267::AID-JMV20>3.0.CO;2-8","article-title":"Type 1-like immune response is found in children with respiratory syncytial virus infection regardless of clinical severity","volume":"62","author":"Brandenburg","year":"2000","journal-title":"J. Med. Virol."},{"issue":"10","key":"10.1016\/j.virusres.2011.09.020_bib0130","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1128\/JCM.38.10.3849-3852.2000","article-title":"G protein variation in respiratory syncytial virus group A does not correlate with clinical severity","volume":"38","author":"Brandenburg","year":"2000","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib0135","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/JVI.74.3.1187-1199.2000","article-title":"Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine","volume":"74","author":"Buchholz","year":"2000","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.virusres.2011.09.020_bib0140","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1128\/JVI.71.12.8973-8982.1997","article-title":"Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse","volume":"71","author":"Bukreyev","year":"1997","journal-title":"J. Virol."},{"issue":"24","key":"10.1016\/j.virusres.2011.09.020_bib0145","doi-asserted-by":"crossref","first-page":"12191","DOI":"10.1128\/JVI.01604-08","article-title":"The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes","volume":"82","author":"Bukreyev","year":"2008","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0150","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1006\/viro.2000.0279","article-title":"Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies","volume":"271","author":"Calder","year":"2000","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib0155","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/rmv.305","article-title":"Molecular epidemiology of respiratory syncytial virus","volume":"11","author":"Cane","year":"2001","journal-title":"Rev. Med. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0160","first-page":"133","article-title":"Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells","volume":"62","author":"Cannon","year":"1987","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0165","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1542\/peds.2008-1036","article-title":"Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial","volume":"125","author":"Carbonell-Estrany","year":"2010","journal-title":"Pediatrics"},{"issue":"13","key":"10.1016\/j.virusres.2011.09.020_bib0170","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1016\/j.febslet.2010.05.006","article-title":"Direct visualization of the small hydrophobic protein of human respiratory syncytial virus reveals the structural basis for membrane permeability","volume":"584","author":"Carter","year":"2010","journal-title":"FEBS Lett."},{"issue":"Pt 6","key":"10.1016\/j.virusres.2011.09.020_bib0175","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1099\/vir.0.79830-0","article-title":"Biochemical characterization of the respiratory syncytial virus P\u2013P and P\u2013N protein complexes and localization of the P protein oligomerization domain","volume":"85","author":"Castagne","year":"2004","journal-title":"J. Gen. Virol."},{"issue":"6","key":"10.1016\/j.virusres.2011.09.020_bib0180","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1164\/ajrccm.159.6.9811035","article-title":"Association of radiologically ascertained pneumonia before age 3 yr with asthmalike symptoms and pulmonary function during childhood: a prospective study","volume":"159","author":"Castro-Rodriguez","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.virusres.2011.09.020_bib0185","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1128\/JVI.01813-10","article-title":"Soluble respiratory syncytial virus fusion protein in the fully cleaved, pretriggered state is triggered by exposure to low-molarity buffer","volume":"85","author":"Chaiwatpongsakorn","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2011.09.020_bib0190","first-page":"291","article-title":"Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). II. epidemiological aspects of infection in infants and young children","volume":"66","author":"Chanock","year":"1957","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.virusres.2011.09.020_bib0195","first-page":"281","article-title":"Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent. I. Isolation, properties and characterization","volume":"66","author":"Chanock","year":"1957","journal-title":"Am. J. Hyg."},{"issue":"9","key":"10.1016\/j.virusres.2011.09.020_bib0200","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1128\/AAC.00211-07","article-title":"RSV604, a novel inhibitor of respiratory syncytial virus replication","volume":"51","author":"Chapman","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"42","key":"10.1016\/j.virusres.2011.09.020_bib0205","doi-asserted-by":"crossref","first-page":"15046","DOI":"10.1073\/pnas.0406696101","article-title":"Targeting a binding pocket within the trimer-of-hairpins: small-molecule inhibition of viral fusion","volume":"101","author":"Cianci","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6140","key":"10.1016\/j.virusres.2011.09.020_bib0210","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/bmj.2.6140.796","article-title":"Respiratory syncytial virus infection: admissions to hospital in industrial, urban, and rural areas. Report to the Medical Research Council Subcommittee on Respiratory Syncytial Virus Vaccines","volume":"2","author":"Clarke","year":"1978","journal-title":"Br. Med. J."},{"issue":"10","key":"10.1016\/j.virusres.2011.09.020_bib0215","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.4049\/jimmunol.0901373","article-title":"Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients","volume":"183","author":"Collarini","year":"2009","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.virusres.2011.09.020_bib0220","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1128\/JVI.01625-07","article-title":"Viral and host factors in human respiratory syncytial virus pathogenesis","volume":"82","author":"Collins","year":"2008","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0225","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1073\/pnas.93.1.81","article-title":"Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus","volume":"93","author":"Collins","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Pt 7","key":"10.1016\/j.virusres.2011.09.020_bib0230","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1099\/0022-1317-74-7-1445","article-title":"Membrane orientation and oligomerization of the small hydrophobic protein of human respiratory syncytial virus","volume":"74","author":"Collins","year":"1993","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2011.09.020_bib0235","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1513\/pats.200501-011AW","article-title":"New generation live vaccines against human respiratory syncytial virus designed by reverse genetics","volume":"2","author":"Collins","year":"2005","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"15","key":"10.1016\/j.virusres.2011.09.020_bib0240","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1073\/pnas.84.15.5134","article-title":"Gene overlap and site-specific attenuation of transcription of the viral polymerase L gene of human respiratory syncytial virus","volume":"84","author":"Collins","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib0245","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1128\/JVI.65.3.1634-1637.1991","article-title":"Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived","volume":"65","author":"Connors","year":"1991","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.virusres.2011.09.020_bib0250","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1128\/JVI.68.8.5321-5325.1994","article-title":"Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB\/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10","volume":"68","author":"Connors","year":"1994","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.virusres.2011.09.020_bib0255","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1128\/JVI.66.12.7444-7451.1992","article-title":"Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB\/c mice is abrogated by depletion of CD4+ T cells","volume":"66","author":"Connors","year":"1992","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.virusres.2011.09.020_bib0260","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/0264-410X(94)90286-0","article-title":"A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees","volume":"12","author":"Crowe","year":"1994","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.virusres.2011.09.020_bib0265","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0264-410X(94)00074-W","article-title":"Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization","volume":"13","author":"Crowe","year":"1995","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.virusres.2011.09.020_bib0270","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.4049\/jimmunol.167.7.3910","article-title":"Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines","volume":"167","author":"Crowe","year":"2001","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.virusres.2011.09.020_bib0275","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1084\/jem.20020943","article-title":"Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood","volume":"196","author":"Culley","year":"2002","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib0280","first-page":"527","article-title":"Rehospitalization for respiratory illness in infants of less than 32 weeks\u2019 gestation","volume":"88","author":"Cunningham","year":"1991","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib0285","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1128\/JVI.69.2.849-855.1995","article-title":"An N-terminal domain of the Sendai paramyxovirus P protein acts as a chaperone for the NP protein during the nascent chain assembly step of genome replication","volume":"69","author":"Curran","year":"1995","journal-title":"J. Virol."},{"issue":"33","key":"10.1016\/j.virusres.2011.09.020_bib0290","doi-asserted-by":"crossref","first-page":"23514","DOI":"10.1074\/jbc.M604292200","article-title":"Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn)","volume":"281","author":"Dall\u2019Acqua","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib0295","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1067\/mpd.2001.111277","article-title":"Detection of IgA and IgG but not IgE antibody to respiratory syncytial virus in nasal washes and sera from infants with wheezing","volume":"138","author":"De Alarcon","year":"2001","journal-title":"J. Pediatr."},{"issue":"9","key":"10.1016\/j.virusres.2011.09.020_bib0300","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.4049\/jimmunol.175.9.5904","article-title":"Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells","volume":"175","author":"de Graaff","year":"2005","journal-title":"J. Immunol."},{"issue":"51","key":"10.1016\/j.virusres.2011.09.020_bib0305","doi-asserted-by":"crossref","first-page":"8518","DOI":"10.1016\/j.vaccine.2007.10.022","article-title":"Immunization of macaques with formalin-inactivated human metapneumovirus induces hypersensitivity to hMPV infection","volume":"25","author":"de Swart","year":"2007","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.virusres.2011.09.020_bib0310","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.vaccine.2003.10.008","article-title":"Evaluation of BBG2Na in infant macaques: specific immune responses after vaccination and RSV challenge","volume":"22","author":"de Waal","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0315","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nm.1894","article-title":"Lack of antibody affinity maturation due to poor toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease","volume":"15","author":"Delgado","year":"2009","journal-title":"Nat. Med."},{"issue":"19","key":"10.1016\/j.virusres.2011.09.020_bib0320","doi-asserted-by":"crossref","first-page":"8800","DOI":"10.1073\/pnas.0912186107","article-title":"A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus","volume":"107","author":"DeVincenzo","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.virusres.2011.09.020_bib0325","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1086\/430008","article-title":"Respiratory syncytial virus load predicts disease severity in previously healthy infants","volume":"191","author":"DeVincenzo","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2011.09.020_bib0330","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1743-422X-5-105","article-title":"Impairment of the CD8+ T cell response in lungs following infection with human respiratory syncytial virus is specific to the anatomical site rather than the virus, antigen, or route of infection","volume":"5","author":"DiNapoli","year":"2008","journal-title":"Virol. J."},{"issue":"8","key":"10.1016\/j.virusres.2011.09.020_bib0335","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/jir.2010.0078","article-title":"Interferon-lambda: a new addition to an old family","volume":"30","author":"Donnelly","year":"2010","journal-title":"J. Interferon Cytokine Res."},{"issue":"6","key":"10.1016\/j.virusres.2011.09.020_bib0340","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1128\/AAC.49.6.2460-2466.2005","article-title":"Small molecules VP-14637 and JNJ-2408068 inhibit respiratory syncytial virus fusion by similar mechanisms","volume":"49","author":"Douglas","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib0345","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/infdis\/174.3.456","article-title":"Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults","volume":"174","author":"Dowell","year":"1996","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.virusres.2011.09.020_bib0350","doi-asserted-by":"crossref","first-page":"8384","DOI":"10.1128\/JVI.73.10.8384-8392.1999","article-title":"Casein kinase 2-mediated phosphorylation of respiratory syncytial virus phosphoprotein P is essential for the transcription elongation activity of the viral polymerase; phosphorylation by casein kinase 1 occurs mainly at Ser(215) and is without effect","volume":"73","author":"Dupuy","year":"1999","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib0355","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jpeds.2009.09.043","article-title":"Surfactant protein A2 polymorphisms and disease severity in a respiratory syncytial virus-infected population","volume":"156","author":"El Saleeby","year":"2010","journal-title":"J. Pediatr."},{"issue":"7","key":"10.1016\/j.virusres.2011.09.020_bib0360","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1128\/JVI.02303-06","article-title":"Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase","volume":"81","author":"Elliott","year":"2007","journal-title":"J. Virol."},{"issue":"41","key":"10.1016\/j.virusres.2011.09.020_bib0365","doi-asserted-by":"crossref","first-page":"7132","DOI":"10.1016\/j.vaccine.2007.07.065","article-title":"Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB\/c mice and functional serum antibodies in rhesus macaques","volume":"25","author":"Elliott","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.virusres.2011.09.020_bib0370","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/adc.71.5.428","article-title":"Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection","volume":"71","author":"Everard","year":"1994","journal-title":"Arch. Dis. Child."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib0375","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-2007-976489","article-title":"Respiratory syncytial virus infection in adults","volume":"28","author":"Falsey","year":"2007","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"17","key":"10.1016\/j.virusres.2011.09.020_bib0380","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"352","author":"Falsey","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2011.09.020_bib0385","unstructured":"Falsey, A.R., Koval, C., Khorana, M., Walsh, E.E., Sorrentino, M.S., Grossman, A., Betts, R.F., 2009. Use of high titer RSV immunoglobulin (RI-001-RSV-IVIG) in immunocompromised adults. Infectious Disease Society of America 47th Annual Meeting, Presentation 607."},{"issue":"11","key":"10.1016\/j.virusres.2011.09.020_bib0390","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/jmv.20724","article-title":"Serum antibody decay in adults following natural respiratory syncytial virus infection","volume":"78","author":"Falsey","year":"2006","journal-title":"J. Med. Virol."},{"issue":"10","key":"10.1016\/j.virusres.2011.09.020_bib0395","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0264-410X(97)00002-9","article-title":"Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly","volume":"15","author":"Falsey","year":"1997","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib0400","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1086\/517376","article-title":"Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults","volume":"177","author":"Falsey","year":"1998","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.virusres.2011.09.020_bib0405","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1086\/592168","article-title":"Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines \u2013 nonadjuvanted vaccine or vaccine adjuvanted with alum \u2013 given concomitantly with influenza vaccine to high-risk elderly individuals","volume":"198","author":"Falsey","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0410","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1128\/JVI.73.1.388-397.1999","article-title":"Model for polymerase access to the overlapped L gene of respiratory syncytial virus","volume":"73","author":"Fearns","year":"1999","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.virusres.2011.09.020_bib0415","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.1128\/JVI.73.7.5852-5864.1999","article-title":"Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription","volume":"73","author":"Fearns","year":"1999","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib0420","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1128\/JVI.76.4.1663-1672.2002","article-title":"Mapping the transcription and replication promoters of respiratory syncytial virus","volume":"76","author":"Fearns","year":"2002","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.virusres.2011.09.020_bib0425","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1128\/JVI.73.8.6610-6617.1999","article-title":"Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G","volume":"73","author":"Feldman","year":"1999","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib0430","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1067\/S0022-3476(03)00454-2","article-title":"Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease","volume":"143","author":"Feltes","year":"2003","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib0435","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0022-3476(80)80799-2","article-title":"Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity","volume":"96","author":"Fishaut","year":"1980","journal-title":"J. Pediatr."},{"issue":"8","key":"10.1016\/j.virusres.2011.09.020_bib0440","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/jama.203.8.690","article-title":"Low-temperature-grown RS virus in adult volunteers","volume":"203","author":"Friedewald","year":"1968","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.virusres.2011.09.020_bib0445","doi-asserted-by":"crossref","first-page":"8361","DOI":"10.1128\/JVI.02717-06","article-title":"Function of the respiratory syncytial virus small hydrophobic protein","volume":"81","author":"Fuentes","year":"2007","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virusres.2011.09.020_bib0450","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1110\/ps.073366208","article-title":"Structure and ion channel activity of the human respiratory syncytial virus (hRSV) small hydrophobic protein transmembrane domain","volume":"17","author":"Gan","year":"2008","journal-title":"Protein Sci."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib0455","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1128\/JVI.70.2.801-808.1996","article-title":"Identification of protein regions involved in the interaction of human respiratory syncytial virus phosphoprotein and nucleoprotein: significance for nucleocapsid assembly and formation of cytoplasmic inclusions","volume":"70","author":"Garcia-Barreno","year":"1996","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0460","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0022-3476(05)80592-X","article-title":"Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection","volume":"120","author":"Garofalo","year":"1992","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib0465","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jaci.2005.01.057","article-title":"Effects of viral respiratory infections on lung development and childhood asthma","volume":"115","author":"Gern","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.virusres.2011.09.020_bib0470","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00705-003-0112-y","article-title":"The matrix protein of human respiratory syncytial virus localises to the nucleus of infected cells and inhibits transcription","volume":"148","author":"Ghildyal","year":"2003","journal-title":"Arch. Virol."},{"issue":"10","key":"10.1016\/j.virusres.2011.09.020_bib0475","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1517\/14712590903287499","article-title":"Motavizumab for the prevention of respiratory syncytial virus infection in infants","volume":"9","author":"Gill","year":"2009","journal-title":"Expert Opin. Biol. Ther."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0480","doi-asserted-by":"crossref","first-page":"L64","DOI":"10.1152\/ajplung.90640.2008","article-title":"Surfactant protein C-deficient mice are susceptible to respiratory syncytial virus infection","volume":"297","author":"Glasser","year":"2009","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"6","key":"10.1016\/j.virusres.2011.09.020_bib0485","first-page":"543","article-title":"Risk of primary infection and reinfection with respiratory syncytial virus","volume":"140","author":"Glezen","year":"1986","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.virusres.2011.09.020_bib0490","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0264-410X(99)00527-7","article-title":"Evaluation of the live attenuated cpts 248\/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults","volume":"18","author":"Gonzalez","year":"2000","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0495","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0014-5793(03)00780-4","article-title":"Viroporins","volume":"552","author":"Gonzalez","year":"2003","journal-title":"FEBS Lett."},{"issue":"17","key":"10.1016\/j.virusres.2011.09.020_bib0500","doi-asserted-by":"crossref","first-page":"9859","DOI":"10.1073\/pnas.151098198","article-title":"Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion","volume":"98","author":"Gonzalez-Reyes","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.virusres.2011.09.020_bib0505","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/pro.5560060619","article-title":"Determination of the disulfide bond arrangement of human respiratory syncytial virus attachment (G) protein by matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry","volume":"6","author":"Gorman","year":"1997","journal-title":"Protein Sci."},{"issue":"23","key":"10.1016\/j.virusres.2011.09.020_bib0510","doi-asserted-by":"crossref","first-page":"21972","DOI":"10.1074\/jbc.M502276200","article-title":"Coupled translation of the respiratory syncytial virus m2 open reading frames requires upstream sequences","volume":"280","author":"Gould","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.virusres.2011.09.020_bib0515","doi-asserted-by":"crossref","first-page":"8488","DOI":"10.1128\/JVI.00457-07","article-title":"Coupled translation of the second open reading frame of M2 mRNA is sequence dependent and differs significantly within the subfamily Pneumovirinae","volume":"81","author":"Gould","year":"2007","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0520","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jmv.1890340103","article-title":"Reinfection of mice with respiratory syncytial virus","volume":"34","author":"Graham","year":"1991","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib0525","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1172\/JCI115362","article-title":"Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice","volume":"88","author":"Graham","year":"1991","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib0530","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1203\/00006450-199308000-00013","article-title":"Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum","volume":"34","author":"Graham","year":"1993","journal-title":"Pediatr. Res."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib0535","first-page":"199","article-title":"Respiratory syncytial virus infection in children with bronchopulmonary dysplasia","volume":"82","author":"Groothuis","year":"1988","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib0540","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1086\/517377","article-title":"Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia","volume":"177","author":"Groothuis","year":"1998","journal-title":"J. Infect. Dis."},{"issue":"21","key":"10.1016\/j.virusres.2011.09.020_bib0545","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJM199311183292102","article-title":"Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group","volume":"329","author":"Groothuis","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"31","key":"10.1016\/j.virusres.2011.09.020_bib0550","doi-asserted-by":"crossref","first-page":"24023","DOI":"10.1074\/jbc.M109.077321","article-title":"Respiratory syncytial virus limits alpha subunit of eukaryotic translation initiation factor 2 (eIF2alpha) phosphorylation to maintain translation and viral replication","volume":"285","author":"Groskreutz","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.virusres.2011.09.020_bib0555","doi-asserted-by":"crossref","first-page":"10190","DOI":"10.1128\/JVI.79.16.10190-10199.2005","article-title":"Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections","volume":"79","author":"Guerrero-Plata","year":"2005","journal-title":"J. Virol."},{"issue":"23","key":"10.1016\/j.virusres.2011.09.020_bib0560","doi-asserted-by":"crossref","first-page":"14992","DOI":"10.1128\/JVI.79.23.14992-14997.2005","article-title":"Human metapneumovirus induces a profile of lung cytokines distinct from that of respiratory syncytial virus","volume":"79","author":"Guerrero-Plata","year":"2005","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib0565","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1165\/rcmb.2005-0287OC","article-title":"Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus","volume":"34","author":"Guerrero-Plata","year":"2006","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib0570","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/sj.gene.6364067","article-title":"Increased in vivo transcription of an IL-8 haplotype associated with respiratory syncytial virus disease-susceptibility","volume":"5","author":"Hacking","year":"2004","journal-title":"Genes Immun."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0575","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-3476(76)80918-3","article-title":"Respiratory syncytial virus infections in infants: quantitation and duration of shedding","volume":"89","author":"Hall","year":"1976","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0580","doi-asserted-by":"crossref","first-page":"53","DOI":"10.7326\/0003-4819-94-1-53","article-title":"Interferon production in adults with respiratory syncytial viral infection","volume":"94","author":"Hall","year":"1981","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0585","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0022-3476(78)80594-0","article-title":"Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections","volume":"93","author":"Hall","year":"1978","journal-title":"J. Pediatr."},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib0590","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0022-3476(84)80005-0","article-title":"Long-term prospective study in children after respiratory syncytial virus infection","volume":"105","author":"Hall","year":"1984","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib0595","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM198607103150201","article-title":"Respiratory syncytial viral infection in children with compromised immune function","volume":"315","author":"Hall","year":"1986","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib0600","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/163.4.693","article-title":"Immunity to and frequency of reinfection with respiratory syncytial virus","volume":"163","author":"Hall","year":"1991","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.virusres.2011.09.020_bib0605","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMoa0804877","article-title":"The burden of respiratory syncytial virus infection in young children","volume":"360","author":"Hall","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2011.09.020_bib0610","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.virol.2010.07.006","article-title":"Roles of the respiratory syncytial virus trailer region: effects of mutations on genome production and stress granule formation","volume":"406","author":"Hanley","year":"2010","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib0615","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.4049\/jimmunol.176.3.1600","article-title":"Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses","volume":"176","author":"Harcourt","year":"2006","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0620","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1128\/JVI.72.1.520-526.1998","article-title":"The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription","volume":"72","author":"Hardy","year":"1998","journal-title":"J. Virol."},{"issue":"13","key":"10.1016\/j.virusres.2011.09.020_bib0625","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1128\/JVI.74.13.5880-5885.2000","article-title":"The Cys(3)-His(1) motif of the respiratory syncytial virus M2-1 protein is essential for protein function","volume":"74","author":"Hardy","year":"2000","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.virusres.2011.09.020_bib0630","doi-asserted-by":"crossref","first-page":"8410","DOI":"10.4049\/jimmunol.179.12.8410","article-title":"CD8+ T cell responses in bronchoalveolar lavage fluid and peripheral blood mononuclear cells of infants with severe primary respiratory syncytial virus infections","volume":"179","author":"Heidema","year":"2007","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.virusres.2011.09.020_bib0635","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.4049\/jimmunol.181.8.5551","article-title":"Dynamics of human respiratory virus-specific CD8+ T cell responses in blood and airways during episodes of common cold","volume":"181","author":"Heidema","year":"2008","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.virusres.2011.09.020_bib0640","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1056\/NEJM197903083001004","article-title":"Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children","volume":"300","author":"Henderson","year":"1979","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib0645","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/viro.2002.1540","article-title":"Sorting of the respiratory syncytial virus matrix protein into detergent-resistant structures is dependent on cell-surface expression of the glycoproteins","volume":"300","author":"Henderson","year":"2002","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.virusres.2011.09.020_bib0650","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1128\/JVI.62.7.2228-2233.1988","article-title":"Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus","volume":"62","author":"Hendricks","year":"1988","journal-title":"J. Virol."},{"issue":"33","key":"10.1016\/j.virusres.2011.09.020_bib0655","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1016\/j.vaccine.2009.05.029","article-title":"Eleven years of Inflexal V \u2013 a virosomal adjuvanted influenza vaccine","volume":"27","author":"Herzog","year":"2009","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.virusres.2011.09.020_bib0660","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJM197006042822302","article-title":"Age as a factor in the distribution of lower-airway conductance and in the pathologic anatomy of obstructive lung disease","volume":"282","author":"Hogg","year":"1970","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0665","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1128\/AAC.21.1.125","article-title":"In vivo inhibition of respiratory syncytial virus by ribavirin","volume":"21","author":"Hruska","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib0670","doi-asserted-by":"crossref","first-page":"e17665","DOI":"10.1371\/journal.pone.0017665","article-title":"Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules","volume":"6","author":"Hultberg","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.virusres.2011.09.020_bib0675","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1086\/520886","article-title":"Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes","volume":"196","author":"Janssen","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.virusres.2011.09.020_bib0680","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1515\/BC.2008.064","article-title":"The coming of age of virus-like particle vaccines","volume":"389","author":"Jennings","year":"2008","journal-title":"Biol. Chem."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0685","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/modpathol.3800725","article-title":"The histopathology of fatal untreated human respiratory syncytial virus infection","volume":"20","author":"Johnson","year":"2007","journal-title":"Mod. Pathol."},{"issue":"10","key":"10.1016\/j.virusres.2011.09.020_bib0690","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1128\/JVI.61.10.3163-3166.1987","article-title":"Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity","volume":"61","author":"Johnson","year":"1987","journal-title":"J. Virol."},{"issue":"16","key":"10.1016\/j.virusres.2011.09.020_bib0695","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1073\/pnas.84.16.5625","article-title":"The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins","volume":"84","author":"Johnson","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.virusres.2011.09.020_bib0700","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1086\/514115","article-title":"Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus","volume":"176","author":"Johnson","year":"1997","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.virusres.2011.09.020_bib0705","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.vaccine.2009.01.041","article-title":"Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV","volume":"27","author":"Jones","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib0710","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF01252772","article-title":"Electron microscopic studies of respiratory syncytial temperature-sensitive mutants","volume":"41","author":"Kalica","year":"1973","journal-title":"Arch. Gesamte Virusforsch."},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib0715","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00006454-200404000-00005","article-title":"Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children","volume":"23","author":"Kanra","year":"2004","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"25","key":"10.1016\/j.virusres.2011.09.020_bib0720","doi-asserted-by":"crossref","first-page":"13961","DOI":"10.1073\/pnas.94.25.13961","article-title":"Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant","volume":"94","author":"Karron","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.virusres.2011.09.020_bib0725","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1086\/427813","article-title":"Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants","volume":"191","author":"Karron","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2011.09.020_bib0730","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1086\/514138","article-title":"Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus (RSV) vaccines in chimpanzees, adults, infants and children","volume":"176","author":"Karron","year":"1997","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib0735","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/viro.2001.0960","article-title":"Deletion and substitution analysis defines regions and residues within the phosphoprotein of bovine respiratory syncytial virus that affect transcription. RNA replication, and interaction with the nucleoprotein","volume":"285","author":"Khattar","year":"2001","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.virusres.2011.09.020_bib0740","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jpeds.2009.12.001","article-title":"A randomized intervention of montelukast for post-bronchiolitis: effect on eosinophil degranulation","volume":"156","author":"Kim","year":"2010","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0745","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1067\/mai.2003.1618","article-title":"Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis","volume":"112","author":"Kim","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0750","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1203\/00006450-197601000-00015","article-title":"Cell-mediated immunity to respiratory syncytial virus induced by inactivated vaccine or by infection","volume":"10","author":"Kim","year":"1976","journal-title":"Pediatr. Res."},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib0755","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.antiviral.2003.09.008","article-title":"Isolation and characterization of NMSO3-resistant mutants of respiratory syncytial virus","volume":"61","author":"Kimura","year":"2004","journal-title":"Antiviral Res."},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib0760","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cub.2008.01.012","article-title":"Pandemic human viruses cause decline of endangered great apes","volume":"18","author":"Kondgen","year":"2008","journal-title":"Curr. Biol."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0765","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1586\/eri.10.140","article-title":"Respiratory syncytial virus disease: update on treatment and prevention","volume":"9","author":"Krilov","year":"2011","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib0770","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jaci.2005.07.012","article-title":"Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response","volume":"116","author":"Kristjansson","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib0775","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1128\/JVI.69.2.1261-1264.1995","article-title":"Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus","volume":"69","author":"Kulkarni","year":"1995","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib0780","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2007.07.013","article-title":"Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses","volume":"27","author":"Kumagai","year":"2007","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.virusres.2011.09.020_bib0785","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1128\/JVI.71.7.4944-4953.1997","article-title":"Analysis of the gene start and gene end signals of human respiratory syncytial virus: quasi-templated initiation at position 1 of the encoded mRNA","volume":"71","author":"Kuo","year":"1997","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.virusres.2011.09.020_bib0790","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1128\/JVI.70.10.6892-6901.1996","article-title":"Effect of mutations in the gene-start and gene-end sequence motifs on transcription of monocistronic and dicistronic minigenomes of respiratory syncytial virus","volume":"70","author":"Kuo","year":"1996","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virusres.2011.09.020_bib0795","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/80833","article-title":"Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus","volume":"1","author":"Kurt-Jones","year":"2000","journal-title":"Nat. Immunol."},{"issue":"20","key":"10.1016\/j.virusres.2011.09.020_bib0800","doi-asserted-by":"crossref","first-page":"10710","DOI":"10.1128\/JVI.00986-09","article-title":"Respiratory syncytial virus grown in Vero cells contains a truncated attachment protein that alters its infectivity and dependence on glycosaminoglycans","volume":"83","author":"Kwilas","year":"2009","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.virusres.2011.09.020_bib0805","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/INF.0b013e3181a165e4","article-title":"Safety and antiviral activity of motavizumab, a respiratory syncytial virus (RSV)-specific humanized monoclonal antibody, when administered to RSV-infected children","volume":"28","author":"Lagos","year":"2009","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"11","key":"10.1016\/j.virusres.2011.09.020_bib0810","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1086\/383350","article-title":"Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy","volume":"189","author":"Laham","year":"2004","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0815","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.1993.1561","article-title":"Paramyxovirus fusion: a hypothesis for changes","volume":"197","author":"Lamb","year":"1993","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.virusres.2011.09.020_bib0820","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1073\/pnas.93.5.2186","article-title":"Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion","volume":"93","author":"Lambert","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib0825","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jcv.2006.07.006","article-title":"Novel mutations in the respiratory syncytial virus G gene identified in viral isolates from a girl with severe combined immune deficiency treated with intravenous immune globulin","volume":"37","author":"Lazar","year":"2006","journal-title":"J. Clin. Virol."},{"issue":"11","key":"10.1016\/j.virusres.2011.09.020_bib0830","doi-asserted-by":"crossref","first-page":"e15017","DOI":"10.1371\/journal.pone.0015017","article-title":"Effects of human respiratory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza virus on CD4+ T cell activation by dendritic cells","volume":"5","author":"Le Nouen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.virusres.2011.09.020_bib0835","doi-asserted-by":"crossref","first-page":"e1002105","DOI":"10.1371\/journal.ppat.1002105","article-title":"Low CCR7-mediated migration of human monocyte derived dendritic cells in response to human respiratory syncytial virus (HRSV) and metapneumovirus (HMPV)","volume":"7","author":"Le Nouen","year":"2011","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0840","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.virol.2008.11.043","article-title":"Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3","volume":"385","author":"Le Nouen","year":"2009","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.virusres.2011.09.020_bib0845","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1086\/518249","article-title":"Human infant respiratory syncytial virus (RSV)-specific type 1 and 2 cytokine responses ex vivo during primary RSV infection","volume":"195","author":"Lee","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.virusres.2011.09.020_bib0850","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1164\/rccm.200210-1148OC","article-title":"Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis","volume":"168","author":"Legg","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.virusres.2011.09.020_bib0855","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/PCC.0b013e31818c82b4","article-title":"A prospective randomized controlled blinded study of three bronchodilators in infants with respiratory syncytial virus bronchiolitis on mechanical ventilation","volume":"9","author":"Levin","year":"2008","journal-title":"Pediatr. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib0860","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1165\/rcmb.2003-0107OC","article-title":"Surfactant protein-d enhances phagocytosis and pulmonary clearance of respiratory syncytial virus","volume":"31","author":"LeVine","year":"2004","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"Pt 9","key":"10.1016\/j.virusres.2011.09.020_bib0865","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1099\/0022-1317-68-9-2521","article-title":"Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus","volume":"68","author":"Levine","year":"1987","journal-title":"J. Gen. Virol."},{"issue":"5","key":"10.1016\/j.virusres.2011.09.020_bib0870","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nri2075","article-title":"Innate immunity of the newborn: basic mechanisms and clinical correlates","volume":"7","author":"Levy","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.virusres.2011.09.020_bib0875","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1128\/JVI.02434-08","article-title":"Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I","volume":"83","author":"Ling","year":"2009","journal-title":"J. Virol."},{"issue":"20","key":"10.1016\/j.virusres.2011.09.020_bib0880","doi-asserted-by":"crossref","first-page":"13105","DOI":"10.1128\/JVI.79.20.13105-13115.2005","article-title":"Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase","volume":"79","author":"Liuzzi","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2011.09.020_bib0885","doi-asserted-by":"crossref","first-page":"9315","DOI":"10.1128\/JVI.79.14.9315-9319.2005","article-title":"Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha\/beta interferon responsiveness","volume":"79","author":"Lo","year":"2005","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.virusres.2011.09.020_bib0890","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/ppul.21248","article-title":"Toll-like receptor 4 Asp299Gly polymorphism in respiratory syncytial virus epidemics","volume":"45","author":"Lofgren","year":"2010","journal-title":"Pediatr. Pulmonol."},{"issue":"5","key":"10.1016\/j.virusres.2011.09.020_bib0895","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1164\/ajrccm.151.5.7735633","article-title":"Sequelae of respiratory syncytial virus infections. A role for intervention studies","volume":"151","author":"Long","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.virusres.2011.09.020_bib0905","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1128\/JVI.01807-09","article-title":"A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants","volume":"84","author":"Lukens","year":"2010","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib0910","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.antiviral.2010.10.004","article-title":"Two novel fusion inhibitors of human respiratory syncytial virus","volume":"88","author":"Lundin","year":"2010","journal-title":"Antiviral Res."},{"issue":"41","key":"10.1016\/j.virusres.2011.09.020_bib0915","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1016\/j.vaccine.2009.07.022","article-title":"Codon stabilization analysis of the \u201c248\u201d temperature sensitive mutation for increased phenotypic stability of respiratory syncytial virus vaccine candidates","volume":"27","author":"Luongo","year":"2009","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.virusres.2011.09.020_bib0920","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJM198208123070702","article-title":"Respiratory syncytial viral infection in infants with congenital heart disease","volume":"307","author":"MacDonald","year":"1982","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.virusres.2011.09.020_bib0925","doi-asserted-by":"crossref","first-page":"7970","DOI":"10.1128\/JVI.00447-10","article-title":"Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein","volume":"84","author":"Magro","year":"2010","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virusres.2011.09.020_bib0930","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/314523","article-title":"Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein","volume":"178","author":"Malley","year":"1998","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib0935","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.diagmicrobio.2008.08.002","article-title":"Clinical disease and viral load in children infected with respiratory syncytial virus or human metapneumovirus","volume":"62","author":"Martin","year":"2008","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"6","key":"10.1016\/j.virusres.2011.09.020_bib0940","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1086\/342414","article-title":"Correlation between respiratory syncytial virus genotype and severity of illness","volume":"186","author":"Martinello","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"Pt 10","key":"10.1016\/j.virusres.2011.09.020_bib0945","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1099\/0022-1317-78-10-2419","article-title":"Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants","volume":"78","author":"Martinez","year":"1997","journal-title":"J. Gen. Virol."},{"issue":"Pt 9","key":"10.1016\/j.virusres.2011.09.020_bib0950","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1099\/0022-1317-79-9-2215","article-title":"Enhanced neutralization of human respiratory syncytial virus by mixtures of monoclonal antibodies to the attachment (G) glycoprotein","volume":"79","author":"Martinez","year":"1998","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib0955","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1128\/JVI.78.4.2029-2036.2004","article-title":"Codon substitution mutations at two positions in the L polymerase protein of human parainfluenza virus type 1 yield viruses with a spectrum of attenuation in vivo and increased phenotypic stability in vitro","volume":"78","author":"McAuliffe","year":"2004","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0960","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1128\/JVI.01861-10","article-title":"Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins","volume":"85","author":"McGinnes","year":"2011","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib0965","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1128\/JVI.79.4.2449-2460.2005","article-title":"Identification of internal sequences in the 3\u2032 leader region of human respiratory syncytial virus that enhance transcription and confer replication processivity","volume":"79","author":"McGivern","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib0970","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0022-3476(78)80595-2","article-title":"Interferon in nasal secretions from infants with viral respiratory tract infections","volume":"93","author":"McIntosh","year":"1978","journal-title":"J. Pediatr."},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib0975","first-page":"305","article-title":"Treatment of respiratory viral infection in an immunodeficient infant with ribavirin aerosol","volume":"138","author":"McIntosh","year":"1984","journal-title":"Am. J. Dis. Child."},{"issue":"23","key":"10.1016\/j.virusres.2011.09.020_bib0980","doi-asserted-by":"crossref","first-page":"12236","DOI":"10.1128\/JVI.01579-10","article-title":"Structure of a major antigenic site on the respiratory syncytial virus fusion glycoprotein in complex with neutralizing antibody 101F","volume":"84","author":"McLellan","year":"2010","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib0985","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nsmb.1723","article-title":"Structural basis of respiratory syncytial virus neutralization by motavizumab","volume":"17","author":"McLellan","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.virusres.2011.09.020_bib0990","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1128\/JVI.00555-11","article-title":"Structure of the respiratory syncytial virus fusion glycoprotein in the post-fusion conformation reveals preservation of neutralizing epitopes","volume":"85","author":"McLellan","year":"2011","journal-title":"J. Virol."},{"issue":"9414","key":"10.1016\/j.virusres.2011.09.020_bib0995","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(04)15838-8","article-title":"Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis","volume":"363","author":"McNamara","year":"2004","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.virusres.2011.09.020_bib1000","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/adc.88.10.922","article-title":"Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis","volume":"88","author":"McNamara","year":"2003","journal-title":"Arch. Dis. Child."},{"issue":"5 Pt 2","key":"10.1016\/j.virusres.2011.09.020_bib1005","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0022-3476(94)70186-5","article-title":"Economic impact of viral respiratory disease in children","volume":"124","author":"Meissner","year":"1994","journal-title":"J. Pediatr."},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib1010","first-page":"433","article-title":"Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants","volume":"2","author":"Mejias","year":"2008","journal-title":"Biologics"},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib1015","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/JVI.01783-06","article-title":"C5 modulates airway hyperreactivity and pulmonary eosinophilia during enhanced respiratory syncytial virus disease by decreasing C3a receptor expression","volume":"81","author":"Melendi","year":"2007","journal-title":"J. Virol."},{"issue":"Pt 10","key":"10.1016\/j.virusres.2011.09.020_bib1020","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1099\/0022-1317-78-10-2411","article-title":"Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein","volume":"78","author":"Melero","year":"1997","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib1025","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1083\/jcb.151.2.413","article-title":"Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion","volume":"151","author":"Melikyan","year":"2000","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib1030","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/CMR.00017-08","article-title":"Human genetic factors and respiratory syncytial virus disease severity","volume":"21","author":"Miyairi","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"issue":"6","key":"10.1016\/j.virusres.2011.09.020_bib1035","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ppul.10101","article-title":"Cytokines in severe respiratory syncytial virus bronchiolitis","volume":"33","author":"Mobbs","year":"2002","journal-title":"Pediatr. Pulmonol."},{"issue":"8","key":"10.1016\/j.virusres.2011.09.020_bib1040","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nm1456","article-title":"A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines","volume":"12","author":"Moghaddam","year":"2006","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.virusres.2011.09.020_bib1045","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1073\/pnas.0805740106","article-title":"Surface features of a Mononegavirales matrix protein indicate sites of membrane interaction","volume":"106","author":"Money","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.virusres.2011.09.020_bib1050","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1128\/JVI.01853-08","article-title":"A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction","volume":"83","author":"Moore","year":"2009","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.virusres.2011.09.020_bib1055","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1128\/JVI.00272-10","article-title":"Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections","volume":"84","author":"Mordstein","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2011.09.020_bib1060","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-92-22538","article-title":"Recovery of cytopathic agent from chimpanzees with coryza","volume":"92","author":"Morris","year":"1956","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"Pt 10","key":"10.1016\/j.virusres.2011.09.020_bib1065","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1099\/0022-1317-66-10-2111","article-title":"Two distinct subtypes of human respiratory syncytial virus","volume":"66","author":"Mufson","year":"1985","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2011.09.020_bib1070","doi-asserted-by":"crossref","first-page":"1001336","DOI":"10.1371\/journal.ppat.1001336","article-title":"Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response","volume":"7","author":"Munir","year":"2011","journal-title":"PLoS Pathog."},{"issue":"17","key":"10.1016\/j.virusres.2011.09.020_bib1075","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1128\/JVI.00630-08","article-title":"Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells","volume":"82","author":"Munir","year":"2008","journal-title":"J. Virol."},{"issue":"24","key":"10.1016\/j.virusres.2011.09.020_bib1080","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1016\/S0264-410X(03)00352-9","article-title":"Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women","volume":"21","author":"Munoz","year":"2003","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.virusres.2011.09.020_bib1085","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1128\/JCM.23.6.1009-1014.1986","article-title":"Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection","volume":"23","author":"Murphy","year":"1986","journal-title":"J. Clin. Microbiol."},{"issue":"10","key":"10.1016\/j.virusres.2011.09.020_bib1090","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1128\/JVI.62.10.3907-3910.1988","article-title":"Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses","volume":"62","author":"Murphy","year":"1988","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib1095","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0264-410X(91)90151-U","article-title":"Effect of passive antibody on the immune response of cotton rats to purified F and G glycoproteins of respiratory syncytial virus (RSV)","volume":"9","author":"Murphy","year":"1991","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.virusres.2011.09.020_bib1100","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0264-410X(90)90253-I","article-title":"Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3\u20136 months after immunization","volume":"8","author":"Murphy","year":"1990","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.virusres.2011.09.020_bib1105","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1128\/JCM.26.8.1595-1597.1988","article-title":"Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity","volume":"26","author":"Murphy","year":"1988","journal-title":"J. Clin. Microbiol."},{"issue":"9725","key":"10.1016\/j.virusres.2011.09.020_bib1110","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib1115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/adc.76.4.315","article-title":"Respiratory status and allergy nine to 10 years after acute bronchiolitis","volume":"76","author":"Noble","year":"1997","journal-title":"Arch. Dis. Child."},{"issue":"22","key":"10.1016\/j.virusres.2011.09.020_bib1120","doi-asserted-by":"crossref","first-page":"10226","DOI":"10.1073\/pnas.0913065107","article-title":"Evidence that the polymerase of respiratory syncytial virus initiates RNA replication in a nontemplated fashion","volume":"107","author":"Noton","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.virusres.2011.09.020_bib1125","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1128\/JVI.63.5.2019-2029.1989","article-title":"The 1A protein of respiratory syncytial virus is an integral membrane protein present as multiple, structurally distinct species","volume":"63","author":"Olmsted","year":"1989","journal-title":"J. Virol."},{"issue":"19","key":"10.1016\/j.virusres.2011.09.020_bib1130","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1073\/pnas.83.19.7462","article-title":"Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity","volume":"83","author":"Olmsted","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.virusres.2011.09.020_bib1135","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.4049\/jimmunol.181.11.7958","article-title":"The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia","volume":"181","author":"Olson","year":"2008","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.virusres.2011.09.020_bib1140","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.4049\/jimmunol.179.8.5415","article-title":"CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease","volume":"179","author":"Olson","year":"2007","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.virusres.2011.09.020_bib1145","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/00006454-199409000-00008","article-title":"Safety and immunogenicity of a subunit respiratory syncytial virus vaccine in children 24 to 48 months old","volume":"13","author":"Paradiso","year":"1994","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.virusres.2011.09.020_bib1150","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004878","article-title":"Glucocorticoids for acute viral bronchiolitis in infants and young children","volume":"3","author":"Patel","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib1155","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/viro.1997.8696","article-title":"Membrane permeability changes induced in Escherichia coli by the SH protein of human respiratory syncytial virus","volume":"235","author":"Perez","year":"1997","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.virusres.2011.09.020_bib1160","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1182\/blood-2007-01-071340","article-title":"Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus","volume":"110","author":"Phipps","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib1165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00006454-199601000-00006","article-title":"Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis","volume":"15","author":"Piedra","year":"1996","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"25","key":"10.1016\/j.virusres.2011.09.020_bib1170","doi-asserted-by":"crossref","first-page":"8996","DOI":"10.1073\/pnas.0409478102","article-title":"The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin","volume":"102","author":"Polack","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.virusres.2011.09.020_bib1175","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1086\/324426","article-title":"Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults","volume":"184","author":"Power","year":"2001","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.virusres.2011.09.020_bib1180","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1128\/JVI.02541-07","article-title":"Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development","volume":"82","author":"Pribul","year":"2008","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib1190","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0168-1702(85)90045-0","article-title":"Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat","volume":"3","author":"Prince","year":"1985","journal-title":"Virus Res."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib1195","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/IAI.42.1.81-87.1983","article-title":"Mechanisms of immunity to respiratory syncytial virus in cotton rats","volume":"42","author":"Prince","year":"1983","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib1200","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1128\/JVI.55.3.517-520.1985","article-title":"Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats","volume":"55","author":"Prince","year":"1985","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2011.09.020_bib1205","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1086\/315894","article-title":"Treatment of respiratory syncytial virus bronchiolitis and pneumonia in a cotton rat model wit systemically administered monoclonal antibody (palivizumab) and glucocorticosteroid","volume":"182","author":"Prince","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.virusres.2011.09.020_bib1210","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1651-2227.2009.01463.x","article-title":"Montelukast does not prevent reactive airway disease in young children hospitalized for RSV bronchiolitis","volume":"98","author":"Proesmans","year":"2009","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.virusres.2011.09.020_bib1215","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2466-7-6","article-title":"Surfactant protein B polymorphisms are associated with severe respiratory syncytial virus infection, but not with asthma","volume":"7","author":"Puthothu","year":"2007","journal-title":"BMC Pulm. Med."},{"issue":"6","key":"10.1016\/j.virusres.2011.09.020_bib1220","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1165\/rcmb.2003-0410OC","article-title":"Specific inhibition of type I interferon signal transduction by respiratory syncytial virus","volume":"30","author":"Ramaswamy","year":"2004","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib1225","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.virol.2005.09.009","article-title":"Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction","volume":"344","author":"Ramaswamy","year":"2006","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.virusres.2011.09.020_bib1230","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1128\/JVI.02065-10","article-title":"Recombinant Sendai viruses expressing fusion proteins with two furin cleavage sites mimic the syncytial and receptor-independent infection properties of respiratory syncytial virus","volume":"85","author":"Rawling","year":"2011","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.virusres.2011.09.020_bib1235","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1128\/JVI.00078-08","article-title":"Insertion of the two cleavage sites of the respiratory syncytial virus fusion protein in Sendai virus fusion protein leads to enhanced cell\u2013cell fusion and a decreased dependency on the HN attachment protein for activity","volume":"82","author":"Rawling","year":"2008","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.virusres.2011.09.020_bib1240","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1086\/593173","article-title":"Macrophage impairment underlies airway occlusion in primary respiratory syncytial virus bronchiolitis","volume":"198","author":"Reed","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.virusres.2011.09.020_bib1245","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1128\/JVI.68.7.4538-4546.1994","article-title":"The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons","volume":"68","author":"Roberts","year":"1994","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib1250","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0022-3476(94)70139-3","article-title":"Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial","volume":"125","author":"Rodriguez","year":"1994","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib1255","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1164\/ajrccm.156.1.9611050","article-title":"Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response","volume":"156","author":"Roman","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.virusres.2011.09.020_bib1260","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1189\/jlb.70.5.691","article-title":"Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens","volume":"70","author":"Rosenberg","year":"2001","journal-title":"J. Leukoc. Biol."},{"issue":"Pt 10","key":"10.1016\/j.virusres.2011.09.020_bib1265","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1099\/0022-1317-73-10-2737","article-title":"Antigenic and genetic characterization of the haemagglutinins of recent cocirculating strains of influenza B virus","volume":"73","author":"Rota","year":"1992","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib1270","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2249.2007.03497.x","article-title":"Differential response of human naive and memory\/effector T cells to dendritic cells infected by respiratory syncytial virus","volume":"150","author":"Rothoeft","year":"2007","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib1275","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1073\/pnas.0910108106","article-title":"Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein","volume":"107","author":"Roymans","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"15","key":"10.1016\/j.virusres.2011.09.020_bib1280","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1093\/emboj\/20.15.4024","article-title":"Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion","volume":"20","author":"Russell","year":"2001","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib1285","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1128\/JVI.76.3.1163-1170.2002","article-title":"Respiratory syncytial virus fusion protein mediates inhibition of mitogen-induced T-cell proliferation by contact","volume":"76","author":"Schlender","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2011.09.020_bib1290","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1128\/JVI.76.3.1089-1099.2002","article-title":"Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone","volume":"76","author":"Schmidt","year":"2002","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virusres.2011.09.020_bib1295","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/ppul.21229","article-title":"Interleukin-9 polymorphism in infants with respiratory syncytial virus infection: an opposite effect in boys and girls","volume":"45","author":"Schuurhof","year":"2010","journal-title":"Pediatr. Pulmonol."},{"issue":"40","key":"10.1016\/j.virusres.2011.09.020_bib1300","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1016\/j.vaccine.2009.07.004","article-title":"Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses","volume":"27","author":"Shao","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib1305","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00006454-199902000-00007","article-title":"Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease","volume":"18","author":"Sheeran","year":"1999","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"7","key":"10.1016\/j.virusres.2011.09.020_bib1310","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1086\/591460","article-title":"Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus","volume":"198","author":"Shinoff","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.virusres.2011.09.020_bib1315","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/infdis\/169.6.1368","article-title":"Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin","volume":"169","author":"Siber","year":"1994","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib1320","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/INF.0b013e31818e2aa9","article-title":"Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes","volume":"28","author":"Siezen","year":"2009","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.virusres.2011.09.020_bib1325","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/thx.2009.121582","article-title":"Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life","volume":"65","author":"Sigurs","year":"2010","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib1330","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1164\/rccm.200406-730OC","article-title":"Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13","volume":"171","author":"Sigurs","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib1335","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaci.2010.05.026","article-title":"The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children","volume":"126","author":"Simoes","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.virusres.2011.09.020_bib1340","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ppul.10080","article-title":"Respiratory syncytial virus bronchiolitis: disease severity, interleukin-8, and virus genotype","volume":"33","author":"Smyth","year":"2002","journal-title":"Pediatr. Pulmonol."},{"issue":"12","key":"10.1016\/j.virusres.2011.09.020_bib1345","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/ppul.21109","article-title":"Pediatric obstructive sleep apnea: a potential late consequence of respiratory syncitial virus bronchiolitis","volume":"44","author":"Snow","year":"2009","journal-title":"Pediatr. Pulmonol."},{"issue":"8","key":"10.1016\/j.virusres.2011.09.020_bib1350","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1128\/JVI.78.8.4363-4369.2004","article-title":"Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages","volume":"78","author":"Spann","year":"2004","journal-title":"J. Virol."},{"issue":"9178","key":"10.1016\/j.virusres.2011.09.020_bib1355","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(98)10321-5","article-title":"Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years","volume":"354","author":"Stein","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib1360","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/vim.2009.0016","article-title":"Pulmonary eosinophilia is attenuated by early responding CD8(+) memory T cells in a murine model of RSV vaccine-enhanced disease","volume":"22","author":"Stevens","year":"2009","journal-title":"Viral Immunol."},{"issue":"12","key":"10.1016\/j.virusres.2011.09.020_bib1365","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1128\/JVI.61.12.3855-3861.1987","article-title":"Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus","volume":"61","author":"Stott","year":"1987","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib1370","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2004.12.002","article-title":"YM-53403, a unique anti-respiratory syncytial virus agent with a novel mechanism of action","volume":"65","author":"Sudo","year":"2005","journal-title":"Antiviral Res."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib1375","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jviromet.2006.11.024","article-title":"An improved method for the recovery of recombinant paramyxovirus vaccine candidates suitable for use in human clinical trials","volume":"141","author":"Surman","year":"2007","journal-title":"J. Virol. Methods"},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib1380","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.virol.2010.03.050","article-title":"Structure of the Newcastle disease virus F protein in the post-fusion conformation","volume":"402","author":"Swanson","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2011.09.020_bib1385","doi-asserted-by":"crossref","first-page":"9619","DOI":"10.1073\/pnas.1106536108","article-title":"Structural basis for immunization with post-fusion RSV F to elicit high neutralizing antibody titers","volume":"108","author":"Swanson","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"19","key":"10.1016\/j.virusres.2011.09.020_bib1390","doi-asserted-by":"crossref","first-page":"9682","DOI":"10.1128\/JVI.00715-09","article-title":"Respiratory syncytial virus nonstructural proteins decrease levels of multiple members of the cellular interferon pathways","volume":"83","author":"Swedan","year":"2009","journal-title":"J. Virol."},{"issue":"20","key":"10.1016\/j.virusres.2011.09.020_bib1395","doi-asserted-by":"crossref","first-page":"10102","DOI":"10.1128\/JVI.00599-08","article-title":"Sendai virus C protein plays a role in restricting PKR activation by limiting the generation of intracellular double-stranded RNA","volume":"82","author":"Takeuchi","year":"2008","journal-title":"J. Virol."},{"issue":"50","key":"10.1016\/j.virusres.2011.09.020_bib1400","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1016\/j.vaccine.2008.09.018","article-title":"Development of a PIV-vectored RSV vaccine: preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults","volume":"26","author":"Tang","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib1405","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2249.2008.03591.x","article-title":"Infection of mice with respiratory syncytial virus during neonatal life primes for enhanced antibody and T cell responses on secondary challenge","volume":"153","author":"Tasker","year":"2008","journal-title":"Clin. Exp. Immunol."},{"issue":"5957","key":"10.1016\/j.virusres.2011.09.020_bib1410","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1126\/science.1177634","article-title":"Crystal structure of a nucleocapsid-like nucleoprotein\u2013RNA complex of respiratory syncytial virus","volume":"326","author":"Tawar","year":"2009","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib1415","first-page":"137","article-title":"Monoclonal antibodies protect against respiratory syncytial virus infection in mice","volume":"52","author":"Taylor","year":"1984","journal-title":"Immunology"},{"key":"10.1016\/j.virusres.2011.09.020_bib1420","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nm.2444","article-title":"Identification of nucleolin as a cellular receptor for human respiratory syncytial virus","volume":"17","author":"Tayyari","year":"2011","journal-title":"Nat. Med."},{"issue":"15","key":"10.1016\/j.virusres.2011.09.020_bib1425","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.1128\/JVI.75.15.6825-6834.2001","article-title":"Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and\/or attachment glycoprotein gene","volume":"75","author":"Techaarpornkul","year":"2001","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib1430","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1006\/viro.2001.1340","article-title":"Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus","volume":"294","author":"Techaarpornkul","year":"2002","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.virusres.2011.09.020_bib1435","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1128\/JVI.72.7.5707-5716.1998","article-title":"Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles","volume":"72","author":"Teng","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2011.09.020_bib1440","doi-asserted-by":"crossref","first-page":"9317","DOI":"10.1128\/JVI.74.19.9317-9321.2000","article-title":"Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees","volume":"74","author":"Teng","year":"2000","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib1445","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/viro.2001.1138","article-title":"Contribution of the respiratory syncytial virus g glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo","volume":"289","author":"Teng","year":"2001","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib1450","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.virusres.2011.09.020_bib1455","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1164\/rccm.200809-1471OC","article-title":"Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study","volume":"179","author":"Thomsen","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib1460","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1164\/rccm.200412-1693OC","article-title":"Neurotrophin overexpression in lower airways of infants with respiratory syncytial virus infection","volume":"172","author":"Tortorolo","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"13","key":"10.1016\/j.virusres.2011.09.020_bib1465","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1128\/JVI.00335-09","article-title":"The respiratory syncytial virus M2-1 protein forms tetramers and interacts with RNA and P in a competitive manner","volume":"83","author":"Tran","year":"2009","journal-title":"J. Virol."},{"issue":"15","key":"10.1016\/j.virusres.2011.09.020_bib1470","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.1128\/JVI.00345-10","article-title":"Ten years of global evolution of the human respiratory syncytial virus BA genotype with a 60-nucleotide duplication in the G protein gene","volume":"84","author":"Trento","year":"2010","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.virusres.2011.09.020_bib1475","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/90675","article-title":"CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein","volume":"2","author":"Tripp","year":"2001","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.virusres.2011.09.020_bib1480","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archotol.124.7.777","article-title":"Respiratory syncytial virus and human bronchial epithelium","volume":"124","author":"Tristram","year":"1998","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib1485","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/infdis\/167.1.191","article-title":"Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18\u201336 months old","volume":"167","author":"Tristram","year":"1993","journal-title":"J. Infect. Dis."},{"issue":"15","key":"10.1016\/j.virusres.2011.09.020_bib1490","doi-asserted-by":"crossref","first-page":"8426","DOI":"10.1128\/JVI.77.15.8426-8439.2003","article-title":"Role of alpha\/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins","volume":"77","author":"Valarcher","year":"2003","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virusres.2011.09.020_bib1495","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/eji.200535642","article-title":"Functional impairment of cytotoxic T cells in the lung airways following respiratory virus infections","volume":"36","author":"Vallbracht","year":"2006","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib1500","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1128\/JCM.25.3.559-562.1987","article-title":"Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum","volume":"25","author":"Wagner","year":"1987","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib1505","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1128\/IAI.43.2.756-758.1984","article-title":"Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies","volume":"43","author":"Walsh","year":"1984","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.virusres.2011.09.020_bib1510","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/infdis\/163.3.464","article-title":"Pattern of respiratory syncytial virus epidemics in Finland: two-year cycles with alternating prevalence of groups A and B","volume":"163","author":"Waris","year":"1991","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.virusres.2011.09.020_bib1515","doi-asserted-by":"crossref","first-page":"6935","DOI":"10.1128\/JVI.71.9.6935-6939.1997","article-title":"Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB\/c mice immunized with formalin-inactivated RSV","volume":"71","author":"Waris","year":"1997","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virusres.2011.09.020_bib1520","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1128\/JVI.70.5.2852-2860.1996","article-title":"Respiratory synctial virus infection in BALB\/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern","volume":"70","author":"Waris","year":"1996","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virusres.2011.09.020_bib1525","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0022-3476(80)80547-6","article-title":"The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses","volume":"96","author":"Welliver","year":"1980","journal-title":"J. Pediatr."},{"issue":"15","key":"10.1016\/j.virusres.2011.09.020_bib1530","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJM198110083051501","article-title":"The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection","volume":"305","author":"Welliver","year":"1981","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.virusres.2011.09.020_bib1535","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1086\/512615","article-title":"Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses","volume":"195","author":"Welliver","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.virusres.2011.09.020_bib1540","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1073\/pnas.82.12.4075","article-title":"Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein","volume":"82","author":"Wertz","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.virusres.2011.09.020_bib1545","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1128\/JVI.63.11.4767-4776.1989","article-title":"Structure and cell surface maturation of the attachment glycoprotein of human respiratory syncytial virus in a cell line deficient in O glycosylation","volume":"63","author":"Wertz","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2011.09.020_bib1550","first-page":"232","article-title":"Respiratory syncytial virus infections in immunocompromised adults","volume":"20","author":"Whimbey","year":"2000","journal-title":"Curr. Clin. Top. Infect. Dis."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib1555","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1017\/S0950268804003450","article-title":"The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England & Wales and Finland: seasonality and cross-protection","volume":"133","author":"White","year":"2005","journal-title":"Epidemiol. Infect."},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib1560","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1128\/JVI.73.4.3438-3442.1999","article-title":"Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees","volume":"73","author":"Whitehead","year":"1999","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2011.09.020_bib1565","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1006\/viro.1998.9248","article-title":"A single nucleotide substitution in the transcription start signal of the M2 gene of respiratory syncytial virus vaccine candidate cpts248\/404 is the major determinant of the temperature-sensitive and attenuation phenotypes","volume":"247","author":"Whitehead","year":"1998","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.virusres.2011.09.020_bib1570","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1128\/JVI.72.5.4467-4471.1998","article-title":"Recombinant respiratory syncytial virus (RSV) bearing a set of mutations from cold-passaged RSV is attenuated in chimpanzees","volume":"72","author":"Whitehead","year":"1998","journal-title":"J. Virol."},{"issue":"2\u20133","key":"10.1016\/j.virusres.2011.09.020_bib1575","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.molimm.2009.08.024","article-title":"The human neonatal B cell response to respiratory syncytial virus uses a biased antibody variable gene repertoire that lacks somatic mutations","volume":"47","author":"Williams","year":"2009","journal-title":"Mol. Immunol."},{"issue":"8","key":"10.1016\/j.virusres.2011.09.020_bib1580","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1086\/339822","article-title":"Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus","volume":"185","author":"Wright","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"13","key":"10.1016\/j.virusres.2011.09.020_bib1585","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.1128\/JVI.79.13.8651-8654.2005","article-title":"Growth of respiratory syncytial virus in primary epithelial cells from the human respiratory tract","volume":"79","author":"Wright","year":"2005","journal-title":"J. Virol."},{"issue":"42","key":"10.1016\/j.virusres.2011.09.020_bib1590","doi-asserted-by":"crossref","first-page":"7372","DOI":"10.1016\/j.vaccine.2007.08.014","article-title":"The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines","volume":"25","author":"Wright","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.virusres.2011.09.020_bib1595","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1086\/315859","article-title":"Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy","volume":"182","author":"Wright","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib1600","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1086\/499600","article-title":"The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans","volume":"193","author":"Wright","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2011.09.020_bib1605","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-3-540-72146-8_4","article-title":"Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab","volume":"317","author":"Wu","year":"2007","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"26","key":"10.1016\/j.virusres.2011.09.020_bib1610","doi-asserted-by":"crossref","first-page":"9288","DOI":"10.1073\/pnas.0503989102","article-title":"Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein","volume":"102","author":"Yin","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7072","key":"10.1016\/j.virusres.2011.09.020_bib1615","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nature04322","article-title":"Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation","volume":"439","author":"Yin","year":"2006","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.virusres.2011.09.020_bib1620","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1128\/JVI.00142-10","article-title":"Respiratory syncytial virus-mediated NF-kappa B p65 phosphorylation at serine 536 is dependent on RIG-I, TRAF6, and IKK beta","volume":"84","author":"Yoboua","year":"2010","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virusres.2011.09.020_bib1625","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1164\/rccm.201003-0422OC","article-title":"RNA interference therapy in lung transplant patients infected with respiratory syncytial virus","volume":"183","author":"Zamora","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"11","key":"10.1016\/j.virusres.2011.09.020_bib1630","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1128\/JVI.76.11.5654-5666.2002","article-title":"Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology","volume":"76","author":"Zhang","year":"2002","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2011.09.020_bib1635","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nm1174","article-title":"Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene","volume":"11","author":"Zhang","year":"2005","journal-title":"Nat. Med."},{"issue":"23","key":"10.1016\/j.virusres.2011.09.020_bib1640","doi-asserted-by":"crossref","first-page":"11651","DOI":"10.1128\/JVI.01387-06","article-title":"In vitro and in vivo fitness of respiratory syncytial virus monoclonal antibody escape mutants","volume":"80","author":"Zhao","year":"2006","journal-title":"J. Virol."},{"issue":"26","key":"10.1016\/j.virusres.2011.09.020_bib1645","doi-asserted-by":"crossref","first-page":"14172","DOI":"10.1073\/pnas.260499197","article-title":"Structural characterization of the human respiratory syncytial virus fusion protein core","volume":"97","author":"Zhao","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.virusres.2011.09.020_bib1650","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/infdis\/jiq100","article-title":"Analysis of respiratory syncytial virus preclinical and clinical variants resistant to neutralization by monoclonal antibodies palivizumab and\/or motavizumab","volume":"203","author":"Zhu","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"34","key":"10.1016\/j.virusres.2011.09.020_bib1655","doi-asserted-by":"crossref","first-page":"31642","DOI":"10.1074\/jbc.M102633200","article-title":"Proteolytic activation of respiratory syncytial virus fusion protein. Cleavage at two furin consensus sequences","volume":"276","author":"Zimmer","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/j.virusres.2011.09.020_bib1660","doi-asserted-by":"crossref","first-page":"9157","DOI":"10.1128\/JVI.79.14.9157-9167.2005","article-title":"Genetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G protein","volume":"79","author":"Zlateva","year":"2005","journal-title":"J. Virol."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016817021100373X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016817021100373X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T04:58:15Z","timestamp":1712897895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016817021100373X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":330,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S016817021100373X"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2011.09.020","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}